Search Result "vasculoprotection"
Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 3 Year: 2019 Page: 4175-4184
Author(s): Arduino A. Mangoni,Sara Tommasi,Angelo Zinellu,Salvatore Sotgia,Stefania Bassu,Matteo Piga,Gian L. Erre,Ciriaco Carru
Atorvastatin and Diabetic Vascular Complications
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1549-1554
Author(s): Sho-ichi Yamagishi, Takanori Matsui, Kazuo Nakamura
HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 5 Issue: 6 Year: 2005 Page: 441-453
Author(s): R. Kleemann, T. Kooistra
Anti-Atherothrombogenic Properties of PEDF
Journal: Current Molecular Medicine
Volume: 10 Issue: 3 Year: 2010 Page: 284-291
Author(s): S.-I. Yamagishi, T. Matsui
Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1), a Relevant Target for Diabetic Vasculopathy?
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 8 Issue: 3 Year: 2008 Page: 203-211
Author(s): Genevieve Renier
Effects of Insulin on the Vasculature
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 321-332
Author(s): Danna M. Breen, Adria Giacca
Selective Activation of G Protein-coupled Estrogen Receptor 1Attenuates Atherosclerosis
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 27 Year: 2024 Page: 4312-4319
Author(s): Mohammad Zulqurnain Haider,Ali H. Eid
Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 1 Year: 2014 Page: 2387-2394
Author(s): Angelo Avogaro, Saula de Kreutzenberg, Gianpaolo Fadini
Mechanisms of the Penetration of Blood-Borne Substances into the Brain
Journal: Current Neuropharmacology
Volume: 7 Issue: 2 Year: 2009 Page: 142-149
Author(s): Masaki Ueno
The Intermediate-Conductance Ca2+-Activated K+ Channel (KCa3.1) in Vascular Disease
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2009 Page: 1-11
Author(s): D. L. Tharp, D. K. Bowles